20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
In today’s private equity landscape, the classic levers of value creation are no longer enough. As markets evolve and competition intensifies, governance is emerging…
Read more
Measuring organizational performance is difficult, especially in a way that is both systematic and genuinely useful for decision-making. In a recent Alpha Talks conversation, Ueli…
Read more
Unpacking the root causes behind underperformance and how to resolve them It’s a familiar scene: Over dinner, a client lamenting inconsistent results across their portfolio…
Read more
Receive our news and valuable perspectives on organizational effectiveness each month.
